Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Talogreptide Mesaroxetan
Castration-Resistant Prostate Carcinoma
Clarity Pharmaceuticals Ltd
P1/2
CC
(46)
Tarlatamab
Sinonasal Undifferentiated Carcinoma
University of Arizona
P1/2
CC
(46)
T-Dxd
Gastric Cancer
Iambic Therapeutics, Inc
P1/2
CC
(46)
Teclistamab
Myelodysplastic Syndrome
CellCentric Ltd.
P1/2
CC
(46)
Temuterkib
Colon Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
Temuterkib
Malignant Colon Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(46)
TIL
Glioblastoma
Essen Biotech
P1/2
CC
(46)
Tiragolumab
Kidney Medullary Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(46)
Tiragolumab
Follicular Lymphoma
Hoffmann-La Roche
P1/2
CC
(46)
Tislelizumab
Neuroendocrine Neoplasm
Harbour BioMed (Guangzhou) Co. Ltd.
P1/2
CC
(46)
Tivozanib
Pancreatic Adenocarcinoma
University of Florida
P1/2
CC
(46)
tj-68
Amyotrophic Lateral Sclerosis
Hiroshi Mitsumoto
P1/2
CC
(46)
Tobemstomig
Hepatocellular Carcinoma
Hoffmann-La Roche
P1/2
CC
(46)
Tocilizumab
Endometrial Cancer
Regeneron Pharmaceuticals
P1/2
CC
(46)
Tocilizumab
Ovarian Cancer
Regeneron Pharmaceuticals
P1/2
CC
(46)
Tocilizumab
Head And Neck Squamous Cell Carcinoma
Takeda
P1/2
CC
(46)
Tolinapant
Fallopian Tube Carcinosarcoma
National Cancer Institute (NCI)
P1/2
CC
(46)
Tolinapant
Ovarian Carcinosarcoma
National Cancer Institute (NCI)
P1/2
CC
(46)
Transcon Tlr7/8 Agonist
Cervical Cancer
Ascendis Pharma Oncology Division A/S
P1/2
CC
(46)
Transcon Tlr7/8 Agonist
Melanoma
Ascendis Pharma Oncology Division A/S
P1/2
CC
(46)
Tucidinostat
Cancer
Chinese PLA General Hospital
P1/2
CC
(46)
Tumor-Draining Lymph Node-Derived Lymphocyte
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P1/2
CC
(46)
Ubamatamab
Endometrial Cancer
Regeneron Pharmaceuticals
P1/2
CC
(46)
Valemetostat
Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
Valemetostat
Nasal Cavity And Paranasal Sinus Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(46)
Showing 3301 to 3325 of 6,302 assets
Previous
Page 133 of 253
Next